Madeleine Strach

Dr Madeleine Strach is a Medical Oncologist (Visiting Medical Officer) at Chris O’Brien Lifehouse and Royal Prince Alfred Hospital. Madeleinehas a special interest in Bone and Soft Tissue Tumours (Sarcomas), Appendiceal Tumours, Clinical Trials and Translational Research. She is a member of the Bone and Soft Tissue Tumour, Retroperitoneal Sarcoma and Peritonectomy Unit multidisciplinary teams.

Madeleine completed her medical training (MBBS BMedSc) at the University of Melbourne in 2010 and gained Fellowship of the Royal Australasian College of Physicians (FRACP) in Medical Oncology in 2017, with advanced training at the Peter MacCallum Cancer Centre in Melbourne. She completed a two-year Fellowship in Phase 1 Clinical Trials at Chris O’Brien Lifehouse in 2019, also working during that time in the Bone and Soft Tissue Tumour Unit. She completed a Master of Public Health (MPH) at the University of Sydney in 2020 with a focus on biostatistics and epidemiology.

Madeleine is completing a PhD at the University of Sydney focusing on translational research into novel treatments for appendiceal tumours. She has been awarded a European Society of Medical Oncology (ESMO) Translational Research Fellowship at The Christie NHS Foundation Trust (Manchester UK) and an Australia and New Zealand Sarcoma Association (ANZSA) Clinical Research Fellowship at Chris O’Brien Lifehouse. She has been awarded competitive research grants from the Christie Charitable Fund, the Royal Prince Alfred Cancer Services and the RACP Foundation. Her PhD is supported by a Commonwealth Research Training Program Scholarship.

Location

119-143 Missenden Road, Camperdown NSW, Australia

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.